The European Medicines Agency (EMA) has moved from being within the DG Industry to be within the DG Health & Consumers (DG Sanco).
The newsletter of DG Sanco, already announces that the news of the European Medicines Agency (EMA) will now be part of the EU-Public Health Website.
Next iissue of the Newsletter of the Asian Network of Cardiologists in Radiation Protection is now available
The criteria for release of patients after radionuclide therapy varies widely in different countries. While there is little, if any, difference in scientific aspects as most countries agree on same level of dose for protection of persons involved, the way fears about radiation are handled in different countries has led to variations.
Link to full article on RPOP website
In recent months, several media reports have focussed on radiation risks to patients undergoing CT and radiation treatment and have reported cases of over-exposures both in CT and radiotherapy.
Professional societies (AAPM, IOMP, ASTRO) and regulatory bodies (such as FDA) have shown concern. The FDA is launching a new initiative requiring all high-grade medical imaging machines "to include safety controls that prevent patients from receiving excessive radiation doses" and will urge manufacturers to "install safeguards on their machines that automatically notify operators if they are using a higher-than-recommended dose."
The IAEA has a number of actions that contribute to achieving higher levels of safety and reducing the probability of radiation events.
Link to full article at RPOP
IAEA launches project to develop methodologies to track radiation exposure of patients for Radiation SmartCare
Link toarticle at RPOP
A team of scientists from the Universities of Manchester and Leeds have joined forces with experts in nuclear medicine at Manchester Royal Infirmary, using medical gamma-ray cameras to track radioactive isotopes in soil samples from a US civil nuclear site.
The University of Manchester